| Literature DB >> 28546744 |
Hong Cai1, Guichen Li1, Shanshan Hua1, Yufei Liu1, Li Chen1.
Abstract
BACKGROUND: The purpose of this study was to conduct a meta-analysis and systematic review to assess the effect of exercise on cognitive function in people with chronic diseases.Entities:
Keywords: cognitive function; exercise; physical activity
Mesh:
Year: 2017 PMID: 28546744 PMCID: PMC5436795 DOI: 10.2147/CIA.S135700
Source DB: PubMed Journal: Clin Interv Aging ISSN: 1176-9092 Impact factor: 4.458
Figure 1Flow diagram of literature search.
Patient characteristics of included studies
| First author (year) | Sample characteristics
| Intervention characteristics
| Outcome
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total N | Intervention/control, n | Diagnosis | Baseline MMSE | Age, years | Intervention category | Frequency, min/wk | Duration, weeks | HRmax | Exercise intensity | Selected cognitive measurement | Conclusion | |
| Arcoverde (2013) | 20 | 10/10 | Alzheimer’s disease | 21.15 | 78.75 | Aerobic | 60 | 12 | 60% | Moderate | MMSE | Yes |
| Oh (2012) | 81 | 44/37 | Cancer | Unknown | 62 | Aerobic | 180 | 10 | Unknown | Low | EORTC-cog | Yes |
| Tsai (2013) | 55 | 28/27 | Osteoarthritic knee | 25.45 | 78.91 | Aerobic | 60–120 | 20 | Unknown | Low | MMSE | No |
| Moore (2015) | 40 | 20/20 | Stroke | 28.5 | 69 | Resistance | 135–180 | 19 | 70%–80% | High | ACE-R | Yes |
| Derry (2015) | 200 | 100/100 | Cancer | Unknown | 51.6 | Aerobic | 90 | 12 | Unknown | Low | BCPT-CPS | Yes |
| Varela (2011) | 32 | 17/15 | MCI | 20.77 | 78.3 | Aerobic | 90 | 12 | 40% | Low | MMSE | No |
| Varela (2011) | 30 | 15/15 | MCI | 21.29 | 77.9 | Aerobic | 90 | 12 | 60% | Moderate | MMSE | No |
| Hildreth (2015) | 53 | 26/27 | MCI | 28.7 | 64.5 | Aerobic | 180 | 18 | 50%–60% | Moderate | ADAS-cog | No |
| Lindsay (2014) | 168 | 47/121 | Heart failure | Unknown | 68.98 | Aerobic | 180 | 12 | Unknown | Moderate | MMSE | No |
| Vadiraja (2009) | 88 | 44/44 | Cancer | Unknown | 47.5 | Aerobic | 180 | 6 | Unknown | Low | EORTC-cog | Yes |
| Schmidt (2015) | 98 | 49/49 | Cancer | Unknown | 52.7 | Resistance | 120 | 12 | Unknown | High | EORTC-cog | No |
| Gowans (2001) | 31 | 15/16 | Fibromyalgia | Unknown | 47.94 | Aerobic | 90 | 23 | 60%–75% | Moderate | BDI-cog | Yes |
| Kim (2005) | 35 | 18/17 | Cancer | Unknown | 33.58 | Aerobic | 210 | 6 | Unknown | Low | PFS-cog | Yes |
| Ohman (2016) | 140 | 70/70 | Alzheimer’s disease | 17.75 | 77.9 | Combined | 120 | 48 | Unknown | Low | CDT | No |
| Ohman (2016) | 140 | 70/70 | Alzheimer’s disease | 18.1 | 78.2 | Combined | 120 | 48 | Unknown | Moderate | CDT | No |
| Cancela (2016) | 189 | 73/116 | Alzheimer’s disease | 15.03 | 82.02 | Aerobic | 105 | 60 | Unknown | Low | MMSE | Yes |
| Chattha (2008) | 120 | 59/61 | Climacteric syndrome | Unknown | 48.5 | Aerobic | 300 | 8 | Unknown | Low | SLCT | Yes |
| Cheng (2014) | 74 | 39/35 | Alzheimer’s disease | 18.79 | 81.38 | Aerobic | 180 | 12 | Unknown | Low | MMSE | Yes |
| Christofoletti (2008) | 30 | 17/20 | Alzheimer’s disease | 13.7 | 76.7 | Resistance | 180 | 24 | Unknown | Moderate | MMSE | No |
| Cott (2002) | 56 | 30/26 | Alzheimer’s disease | 5.8 | 82.5 | Aerobic | 150 | 16 | Unknown | Low | FACS | No |
| Hashimoto (2015) | 38 | 19/19 | Parkinson’s disease | 28.25 | 68.77 | Aerobic | 60 | 12 | 50%–70% | Moderate | FAB | Yes |
| Hashimoto (2015) | 40 | 21/19 | Parkinson’s disease | 28.41 | 65.86 | Resistance | 60 | 12 | 50%–70% | Moderate | FAB | Yes |
| Holthoff (2015) | 30 | 15/15 | Alzheimer’s disease | 20.6 | 72.4 | Combined | 90 | 12 | Unknown | Moderate | MMSE | Yes |
| Lam (2015) | 278 | 147/131 | MCI | 25.7 | 75.45 | Aerobic | 180 | 48 | Unknown | Low | MMSE | No |
| Lam (2012) | 261 | 171/218 | MCI | 24.5 | 77.82 | Aerobic | 90 | 48 | Unknown | Low | MMSE | No |
| Lautenschlager (2011) | 170 | 85/85 | MCI | Unknown | 68.65 | Combined | 150 | 24 | Unknown | Moderate | ADAS-cog | Yes |
| Lu (2016) | 46 | 23/23 | MCI | 26.82 | 69.73 | Resistance | 180 | 12 | Unknown | Moderate | ADAS-cog | Yes |
| Miu (2008) | 85 | 36/49 | Alzheimer’s disease | 18.9 | 76.66 | Aerobic | 120 | 12 | Unknown | Moderate | MMSE | No |
| Nascimento (2014) | 37 | 20/17 | MCI | Unknown | 67.7 | Aerobic | 180 | 16 | Unknown | Moderate | MoCA | Yes |
| Kwak (2008) | 30 | 15/15 | Alzheimer’s disease | 14.0 | 81.0 | Combined | 40 | 48 | 40%–60% | Moderate | MMSE | Yes |
| Kemoun (2010) | 38 | 20/18 | Alzheimer’s disease | 12.8 | 81.8 | Aerobic | 180 | 15 | Unknown | Moderate | ERFC | Yes |
| Kim (2011) | 44 | 32/12 | Metabolic syndrome | 26.18 | 68.19 | Aerobic | 120 | 24 | 50%–80% | Moderate to high | TCD | No |
| Stevens (2016) | 54 | 24/30 | Alzheimer’s disease | Unknown | 80.2 | Aerobic | 90 | 12 | Unknown | Moderate | CDT | Yes |
| Suzuki (2013) | 100 | 50/50 | MCI | 26.55 | 75.3 | Combined | 180 | 24 | 60% | Moderate | MMSE | No |
| Suzuki (2012) | 50 | 25/25 | MCI | 26.7 | 76.05 | Combined | 180 | 48 | 60% | Moderate | MMSE | Yes |
| Van (2004) | 25 | 15/10 | Alzheimer’s disease | Unknown | 81.65 | Combined | 210 | 12 | Unknown | Moderate | MMSE | Yes |
| Vreugdenhil (2011) | 40 | 20/20 | Alzheimer’s disease | 22.00 | 74.1 | Combined | 210 | 17.3 | Unknown | Moderate | MMSE | Yes |
| Wei (2014) | 60 | 30/30 | MCI | 24.67 | 66 | Aerobic | 120 | 24 | Unknown | Moderate | MMSE | Yes |
Abbreviations: ACE-R, Addenbrooke’s Cognitive Examination-Revised; ADAS-cog, Alzheimer’s Disease Assessment Scale-cognitive subscale; BCPT-CPS, Breast Cancer Prevention Trial Symptom Checklist-Cognitive Problems Scale; BDI-cog, Beck Depression Inventory-cognitive; CDT, clock drawing test; EORTC-cog, European Organization for Research and Treatment of Cancer-cognitive; ERFC, Rapid Evaluation of Cognitive Function; FAB, Frontal Assessment Battery; FACS, functional assessment of communication skills; HRmax, maximum heart rate; MCI, mild cognitive impairment; MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment; PFS-cog, Piper Fatigue Scale-cognitive; SLCT, six-letter cancellation test; TCD, total cognitive domain.
Quality of included studies
| First author (year) | Reporting (11 points) | External validity (3 points) | Bias (7 points) | Confounding (6 points) | Power (5 points) | Total (32 points) | Quality as per cutoff described |
|---|---|---|---|---|---|---|---|
| Arcoverde (2013) | 10 | 3 | 6 | 3 | 5 | 27 | Good |
| Oh (2012) | 10 | 3 | 5 | 3 | 5 | 26 | Good |
| Tsai (2013) | 8 | 3 | 5 | 3 | 0 | 19 | Moderate |
| Moore (2015) | 9 | 3 | 6 | 1 | 5 | 24 | Good |
| Derry (2015) | 8 | 2 | 5 | 2 | 5 | 17 | Poor |
| Varela (2011) | 8 | 3 | 5 | 3 | 0 | 19 | Moderate |
| Hildreth (2015) | 8 | 2 | 5 | 4 | 0 | 16 | Poor |
| Lindsay (2014) | 8 | 3 | 5 | 4 | 0 | 20 | Moderate |
| Vadiraja (2009) | 10 | 2 | 5 | 4 | 0 | 21 | Moderate |
| Schimidt (2015) | 9 | 3 | 5 | 4 | 0 | 21 | Moderate |
| Gowans (2001) | 9 | 3 | 5 | 4 | 5 | 26 | Good |
| Kim (2005) | 9 | 2 | 5 | 3 | 0 | 19 | Moderate |
| Ohman (2016) | 9 | 2 | 5 | 5 | 0 | 21 | Moderate |
| Cancela (2016) | 9 | 3 | 5 | 4 | 5 | 27 | Good |
| Chattha (2008) | 9 | 3 | 5 | 3 | 5 | 25 | Good |
| Cheng (2014) | 9 | 3 | 5 | 4 | 5 | 26 | Good |
| Cott (2002) | 9 | 2 | 5 | 3 | 0 | 19 | Moderate |
| Christofoletti (2008) | 7 | 2 | 5 | 2 | 0 | 16 | Poor |
| Hashimoto (2015) | 9 | 2 | 5 | 1 | 5 | 22 | Moderate |
| Holthoff (2015) | 9 | 2 | 5 | 2 | 5 | 23 | Moderate |
| Lam (2015) | 10 | 2 | 6 | 4 | 0 | 22 | Moderate |
| Lam (2012) | 8 | 3 | 5 | 3 | 0 | 19 | Moderate |
| Lautenschlager (2011) | 9 | 2 | 5 | 3 | 5 | 24 | Good |
| Lu (2016) | 9 | 2 | 5 | 3 | 5 | 24 | Good |
| Miu (2008) | 10 | 2 | 6 | 4 | 5 | 27 | Good |
| Nascimento (2014) | 8 | 2 | 5 | 2 | 0 | 17 | Poor |
| Kwak (2008) | 9 | 1 | 5 | 4 | 5 | 24 | Moderate |
| Kemoun (2010) | 7 | 3 | 5 | 2 | 5 | 22 | Moderate |
| Kim (2011) | 9 | 3 | 6 | 3 | 5 | 26 | Good |
| Stevens (2016) | 8 | 2 | 5 | 3 | 0 | 18 | Moderate |
| Suzuki (2013) | 9 | 2 | 5 | 4 | 0 | 20 | Moderate |
| Suzuki (2012) | 9 | 2 | 5 | 4 | 5 | 25 | Good |
| Van (2004) | 8 | 2 | 5 | 3 | 5 | 23 | Moderate |
| Vreugdenhil (2011) | 9 | 3 | 5 | 4 | 5 | 26 | Good |
| Wei (2014) | 7 | 2 | 5 | 2 | 5 | 21 | Moderate |
Meta-analysis of effect of exercise on cognitive function
| Parameters | Included studies | N | SMD (95% CI) | |||
|---|---|---|---|---|---|---|
| Main outcome | 35 | 3,113 | 0.0007 | 74% | 3.41 | 0.26 (0.11, 0.41) |
| Alzheimer’s disease | 13 | 958 | 0.004 | 77% | 2.88 | 0.42 (0.14, 0.71) |
| Mild cognitive impairment | 9 | 1,117 | 0.21 | 77% | 1.25 | 0.17 (–0.10, 0.44) |
| Cancer | 5 | 502 | 0.66 | 86% | 0.44 | 0.11 (–0.39, 0.61) |
| Aerobic | 23 | 2,120 | 0.0008 | 70% | 3.34 | 0.29 (0.12, 0.47) |
| Resistance | 5 | 261 | 0.69 | 73% | 0.40 | 0.10 (–0.39, 0.59) |
| Combined | 8 | 725 | 0.14 | 83% | 1.46 | 0.29 (–0.10, 0.67) |
| Aerobic included | 31 | 2,845 | 0.0005 | 75% | 3.47 | 0.28 (0.12, 0.45) |
| High frequency | 18 | 1,494 | 0.07 | 83% | 1.82 | 0.25 (–0.02, 0.52) |
| High frequency (excluded resistance) | 16 | 1,450 | 0.02 | 82% | 2.24 | 0.31 (0.04, 0.57) |
| Low frequency | 16 | 1,547 | 0.0008 | 40% | 2.67 | 0.19 (0.05, 0.33) |
| Low frequency (excluded resistance) | 14 | 1,409 | 0.15 | 60% | 1.43 | 0.13 (−0.05, 0.32) |
| Low | 13 | 1,609 | 0.03 | 77% | 2.12 | 0.24 (0.02, 0.47) |
| Moderate | 21 | 1,322 | 0.03 | 72% | 2.13 | 0.24 (0.02, 0.46) |
| Moderate (excluded resistance) | 19 | 1,199 | 0.008 | 76% | 2.66 | 0.34 (0.09, 0.59) |
| High | 2 | 138 | 0.30 | 0% | 1.04 | 0.18 (−0.16, 0.51) |
Abbreviations: CI, confidence interval; SMD, standardized mean difference.